|
1
|
Landa I, Ganly I, Chan TA, Mitsutake N,
Matsuse M, Ibrahimpasic T, Ghossein RA and Fagin JA: Frequent
somatic TERT promoter mutations in thyroid cancer: higher
prevalence in advanced forms of the disease. J Clin Endocrinol
Metab. 98:E1562–E1566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shay JW and Bacchetti S: A survey of
telomerase activity in human cancer. Eur J Cancer. 33:787–791.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ulaner GA, Hoffman AR, Otero J, Huang HY,
Zhao Z, Mazumdar M, Gorlick R, Meyers P, Healey JH and Ladanyi M:
Divergent patterns of telomere maintenance mechanisms among human
sarcomas: Sharply contrasting prevalence of the alternative
lengthening of telomeres mechanism in Ewing's sarcomas and
osteosarcomas. Genes Chromosomes Cancer. 41:155–162. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Horn S, Figl A, Rachakonda PS, Fischer C,
Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K, et al:
TERT promoter mutations in familial and sporadic melanoma. Science.
339:959–961. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin
L and Garraway LA: Highly recurrent TERT promoter mutations in
human melanoma. Science. 339:957–959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koelsche C, Sahm F, Capper D, Reuss D,
Sturm D, Jones DT, Kool M, Northcott PA, Wiestler B, Böhmer K, et
al: Distribution of TERT promoter mutations in pediatric and adult
tumors of the nervous system. Acta Neuropathol. 126:907–915. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Koelsche C, Renner M, Hartmann W, Brandt
R, Lehner B, Waldburger N, Alldinger I, Schmitt T, Egerer G, Penzel
R, et al: TERT promoter hotspot mutations are recurrent in myxoid
liposarcomas but rare in other soft tissue sarcoma entities. J Exp
Clin Cancer Res. 33:332014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Akaike K, Kurisaki-Arakawa A, Hara K,
Suehara Y, Takagi T, Mitani K, Kaneko K, Yao T and Saito T:
Distinct clinicopathological features of NAB2-STAT6 fusion gene
variants in solitary fibrous tumor with emphasis on the acquisition
of highly malignant potential. Hum Pathol. 46:347–356. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
World Health Organization (WHO)
Classification of Tumours of Soft Tissue. Fletcher CDM, Bridge JA,
Hogendoorn PCW and Mertens F: World Health Organization
International Agency for Research on Cancer. IARC Press. 2013.
|
|
10
|
Borah S, Xi L, Zaug AJ, Powell NM, Dancik
GM, Cohen SB, Costello JC, Theodorescu D and Cech TR: Cancer. TERT
promoter mutations and telomerase reactivation in urothelial
cancer. Science. 347:1006–1010. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu L, Li S and Stohr BA: The role of
telomere biology in cancer. Annu Rev Pathol. 8:49–78. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fanburg-Smith JC, Meis-Kindblom JM, Fante
R and Kindblom LG: Malignant granular cell tumor of soft tissue:
Diagnostic criteria and clinicopathologic correlation. Am J Surg
Pathol. 22:779–794. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saito T, Mitomi H, Torigoe T, Takagi T,
Suehara Y, Okubo T, Kaneko K and Yao T: Malignant granular cell
tumor with an unusually long clinical course: An autopsy case with
review of literature. J Cancer Sci Ther. 4:260–263. 2012.
View Article : Google Scholar
|
|
14
|
Papachristou DJ, Palekar A, Surti U,
Cieply K, McGough RL and Rao UN: Malignant granular cell tumor of
the ulnar nerve with novel cytogenetic and molecular genetic
findings. Cancer Genet Cytogenet. 191:46–50. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Di Tommaso L, Magrini E, Consales A, Poppi
M, Pasquinelli G, Dorji T, Benedetti G and Baccarini P: Malignant
granular cell tumor of the lateral femoral cutaneous nerve: Report
of a case with cytogenetic analysis. Hum Pathol. 33:1237–1240.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dubbink HJ, Bakels H, Post E, Zwarthoff EC
and Verdijk RM: TERT promoter mutations and BRAF mutations are rare
in sporadic, and TERT promoter mutations are absent in NF1-related
malignant peripheral nerve sheath tumors. J Neurooncol.
120:267–272. 2104. View Article : Google Scholar
|
|
17
|
Griewank KG, Schilling B, Murali R,
Bielefeld N, Schwamborn M, Sucker A, Zimmer L, Hillen U, Schaller
J, Brenn T, et al: TERT promoter mutations are frequent in atypical
fibroxanthomas and pleomorphic dermal sarcomas. Mod Pathol.
27:502–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
